Skip to main content

Table 3 Univariate analysis to identify variables associated with short-term and long-term anti-HBs seroconversion rate

From: Two-year immune effect differences between the 0–1–2-month and 0–1–6-month HBV vaccination schedule in adults

Variables

Anti-HBs seroconversion at 2 months

Anti-HBs seroconversion at 2 years

Odds ratio (95% CI)

p value

Odds ratio (95% CI)

p value

Age, years

0.97 (0.95–0.99)

0.007

0.98 (0.97–1.00)

0.165

Male sex

1.17 (0.73–1.90)

0.503

0.73 (0.48–1.11)

0.147

BMI

0.86 (0.81–0.92)

< 0.001

0.91 (0.86–0.96)

0.002

Anti-HBc

0.88 (0.83–0.94)

< 0.001

1.04 (0.98–1.09)

0.148

ALT

0.99 (0.99–1.00)

0.282

1.00 (0.99–1.00)

0.910

0–1–2-month vs. 0–1–6-month (reference) vaccination schedule

0.73 (0.46–1.18)

0.211

1.27 (0.85–1.90)

0.241